Clinical Presentation of T.b. rhodesiense Sleeping Sickness in Tanzania and Uganda
Author Information
Author(s): Kuepfer Irene, Hhary Emma Peter, Allan Mpairwe, Edielu Andrew, Burri Christian, Blum Johannes A.
Primary Institution: Swiss Tropical and Public Health Institute, Basel, Switzerland
Hypothesis
What are the clinical presentations of T.b. rhodesiense HAT in second stage patients from Tanzania and Uganda?
Conclusion
The study found distinct clinical presentations of T.b. rhodesiense HAT in Tanzania and Uganda, highlighting the need for awareness of regional characteristics in diagnosis and treatment.
Supporting Evidence
- The median white blood cell count in the cerebrospinal fluid was significantly higher in Tanzania than in Uganda.
- Neurological signs and symptoms specific for HAT were more common in Tanzania.
- Co-infections with malaria and HIV did not significantly influence clinical presentation or treatment outcomes.
Takeaway
This study looked at how sleeping sickness shows up differently in patients from Tanzania and Uganda, helping doctors know what to look for.
Methodology
The study enrolled 138 second stage patients from Tanzania and Uganda, collecting blood samples for diagnosis and analyzing clinical signs and symptoms.
Potential Biases
Potential biases include selection bias due to the exclusion of certain patients and observation bias in clinical assessments.
Limitations
The study excluded moribund or unconscious patients, which may limit the generalizability of the findings.
Participant Demographics
57.2% male and 42.8% female, with 18.8% under 16 years old.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website